Implantable Insulin Pump Market

Implantable insulin pump aids in delivering insulin into the peritoneal cavity and remains inside the body all the time. In addition, the insulin pump implanted in the peritoneal cavity helps in efficient absorption of insulin. The advent of implantable insulin pumps is anticipated to revolutionize the treatment of Type 1 diabetes and will also help find a constructive solution for truly effective artificial pancreas.

Implantable Insulin Pump Market contains market size and forecasts of Implantable Insulin Pump in global, including the following market information:

Global Implantable Insulin Pump Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Implantable Insulin Pump Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Implantable Insulin Pump companies in 2021 (%)

The global Implantable Insulin Pump market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Closed-Loop Insulin Pump Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Implantable Insulin Pump include Medtronic, Insulet Corporation, F. Hoffmann La Roche Ltd, Animas corporation, SOOIL Developments Co., Ltd, Johnson & Johnson, Tandem Diabetes Care, Inc and Aetna Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Implantable Insulin Pump manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Implantable Insulin Pump Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Insulin Pump Market Segment Percentages, by Type, 2021 (%)

Closed-Loop Insulin Pump

Open-Loop Insulin Pump

Global Implantable Insulin Pump Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Insulin Pump Market Segment Percentages, by Application, 2021 (%)

Hospitals

Individuals (Self-Medication)

Global Implantable Insulin Pump Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Implantable Insulin Pump Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Implantable Insulin Pump revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Implantable Insulin Pump revenues share in global market, 2021 (%)

Key companies Implantable Insulin Pump sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Implantable Insulin Pump sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Medtronic

Insulet Corporation

F. Hoffmann La Roche Ltd

Animas corporation

SOOIL Developments Co., Ltd

Johnson & Johnson

Tandem Diabetes Care, Inc

Aetna Inc